Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The INDSCI-SIM model for COVID-19 in India

View ORCID ProfileDhiraj Kumar Hazra, View ORCID ProfileBhalchandra S. Pujari, View ORCID ProfileSnehal M. Shekatkar, Farhina Mozaffer, View ORCID ProfileSitabhra Sinha, View ORCID ProfileVishwesha Guttal, View ORCID ProfilePinaki Chaudhuri, View ORCID ProfileGautam I. Menon
doi: https://doi.org/10.1101/2021.06.02.21258203
Dhiraj Kumar Hazra
1The Institute of Mathematical Sciences, CIT Campus, Taramani, Chennai 600 113 INDIA
2Homi Bhabha National Institute, BARC Training School Complex, Anushaktinagar, Mumbai 400 094 INDIA
3INAF/OAS Bologna, Osservatorio di Astrofisica e Scienza dello Spazio, Area della ricerca CNR-INAF, via Gobetti 101, I-40129 Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dhiraj Kumar Hazra
Bhalchandra S. Pujari
4Department of Scientific Computing, Modeling, and Simulation, Savitribai Phule Pune University, Ganeshkhind, Pune 411 007 INDIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bhalchandra S. Pujari
Snehal M. Shekatkar
4Department of Scientific Computing, Modeling, and Simulation, Savitribai Phule Pune University, Ganeshkhind, Pune 411 007 INDIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Snehal M. Shekatkar
Farhina Mozaffer
1The Institute of Mathematical Sciences, CIT Campus, Taramani, Chennai 600 113 INDIA
2Homi Bhabha National Institute, BARC Training School Complex, Anushaktinagar, Mumbai 400 094 INDIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sitabhra Sinha
1The Institute of Mathematical Sciences, CIT Campus, Taramani, Chennai 600 113 INDIA
2Homi Bhabha National Institute, BARC Training School Complex, Anushaktinagar, Mumbai 400 094 INDIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sitabhra Sinha
Vishwesha Guttal
5Centre for Ecological Sciences, Indian Institute of Science, C V Raman Avenue, Bengaluru 560 012 INDIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vishwesha Guttal
Pinaki Chaudhuri
1The Institute of Mathematical Sciences, CIT Campus, Taramani, Chennai 600 113 INDIA
2Homi Bhabha National Institute, BARC Training School Complex, Anushaktinagar, Mumbai 400 094 INDIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pinaki Chaudhuri
Gautam I. Menon
1The Institute of Mathematical Sciences, CIT Campus, Taramani, Chennai 600 113 INDIA
2Homi Bhabha National Institute, BARC Training School Complex, Anushaktinagar, Mumbai 400 094 INDIA
6Departments of Physics and Biology, Ashoka University, Plot No. 2, Rajiv Gandhi Education City, NCR P.O.Rai, Sonepat Haryana 131 029 INDIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gautam I. Menon
  • For correspondence: gautam.menon{at}ashoka.edu.in
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Estimating the burden of COVID-19 in India is difficult because the extent to which cases and deaths have been undercounted is hard to assess. The INDSCI-SIM model is a 9-component, age-stratified, contact-structured compartmental model for COVID-19 spread in India. We use INDSCI-SIM, together with Bayesian methods, to obtain optimal fits to reported cases and deaths across the span of the first wave of the Indian pandemic, over the period Jan 30, 2020 to Feb 15, 2021. We account for lock-downs and other non-pharmaceutical interventions, an overall increase in testing as a function of time, the under-counting of cases and deaths, and a range of age-specific infection-fatality ratios. We first use our model to describe data from all individual districts of the state of Karnataka, benchmarking our calculations using data from serological surveys. We then extend this approach to aggregated data for Karnataka state. We model the progress of the pandemic across the cities of Delhi, Mumbai, Pune, Bengaluru and Chennai, and then for India as a whole. We estimate that deaths were undercounted by a factor between 2 and 5 across the span of the first wave, converging on 2.2 as a representative multiplier that accounts for the urban-rural gradient across the country. We also estimate an overall under-counting of cases by a factor of between 20 and 25 towards the end of the first wave. Our estimates of the infection fatality ratio (IFR) are in the range 0.05 - 0.15, broadly consistent with previous estimates but substantially lower than values that have been estimated for other LMIC countries. We find that approximately 40% of India had been infected overall by the end of the first wave, results broadly consistent with those from serosurveys. These results contribute to the understanding of the long-term trajectory of COVID-19 in India.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

SMS acknowledges funding from the DST-INSPIRE Faculty Fellowship (DST/INSPIRE/04/2018/002664) by DST India. GIM thanks the Department of Biological Science, TIFR (Mumbai) for an Adjunct Professorship and acknowledges support of the Bill and Melinda Gates Foundation, Grant No: R/BMG/PHY/GMN/20

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Since this work reports results of modeling only and reproduces only publicly available data, no IRB approval was sought.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

We developed a fast FORTRAN code (ELiXSIR) - Extended, zone Linked IX-compartmental SIR model: a code to simulate COVID19 infection} as a solver for the model. A version of ELiXSIR is available for download in https://gitlab.com/dhirajhazra/eSIR_INDIA. The code is designed for arbitrary numbers of age groups and regions. We acknowledge the use of PolyChord through the publicly available code CosmoChord: https://github.com/williamjameshandley/CosmoChord. ELiXSIR is fused with CosmoChord for the purpose of data analysis and post processing.

https://gitlab.com/dhirajhazra/eSIR_INDIA

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 03, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The INDSCI-SIM model for COVID-19 in India
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The INDSCI-SIM model for COVID-19 in India
Dhiraj Kumar Hazra, Bhalchandra S. Pujari, Snehal M. Shekatkar, Farhina Mozaffer, Sitabhra Sinha, Vishwesha Guttal, Pinaki Chaudhuri, Gautam I. Menon
medRxiv 2021.06.02.21258203; doi: https://doi.org/10.1101/2021.06.02.21258203
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The INDSCI-SIM model for COVID-19 in India
Dhiraj Kumar Hazra, Bhalchandra S. Pujari, Snehal M. Shekatkar, Farhina Mozaffer, Sitabhra Sinha, Vishwesha Guttal, Pinaki Chaudhuri, Gautam I. Menon
medRxiv 2021.06.02.21258203; doi: https://doi.org/10.1101/2021.06.02.21258203

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)